RESULTS &CONCLUSION The countermeasures of regulating drug registration management system and relative rules,strengthening policy guidance,and encouraging drug innovation were suggested.

• 结果和结论完善药品注册管理体系和法律法规的建设,加强政策引导,鼓励新药的自主创新。